Apple Watches are more than just feature-packed wearables; they're important tools for monitoring our health, including our heart rate, sleep patterns, and cardio fitness. Even if you don't know ...

Dexcom launched the Stelo over-the-counter CGM and announced that the 15-day G7 system, cleared by the FDA, will be launched in the second half of 2025. The new system is expected to offer ...

In earnings calls, diabetes tech companies had less to say about tariffs and focused more on future growth.

Dexcom has ceased distribution of G7 sensors with the component, but the company’s response did not address affected G6 sensors. J.P. Morgan analyst Robbie Marcus wrote in a research note ...

announced today the FDA has cleared the Dexcom G7 15 Day Continuous Glucose Monitoring System for people over the age of 18 with diabetes in the United States. With an overall MARD of 8.0% ...

Dexcom reaffirmed its 2025 revenue guidance of ... with evident confidence in key initiatives like the 15-day G7 launch. Revenue growth accelerated to 14% in Q1 2025 from 8% in Q4 2024.